Merck or Pfizer
In this video, Chuck Carnevale, Co-Founder of FAST Graphs, aka Mr. Valuation, is going to take a deep dive into Merck (MRK) and Pfizer (PFE), two of the biggest pharmaceutical companies out there. Chuck is also going to address whether one is a better investment than the other, but also whether we should even be investing in one, both, or none, that’s what research is all about. In addition to this, before you lay your money down you want to conduct a comprehensive research and due diligence process, Chuck will talk about that as well.
FAST Graphs Analyze Out Loud Video on Merck and Pfizer
Disclosure: Long PFE and MRK
Disclaimer: The opinions in this document are for informational and educational purposes only and should not be construed as a recommendation to buy or sell the stocks mentioned or to solicit transactions or clients. Past performance of the companies discussed may not continue and the companies may not achieve the earnings growth as predicted. The information in this document is believed to be accurate, but under no circumstances should a person act upon the information contained within. We do not recommend that anyone act upon any investment information without first consulting an investment advisor as to the suitability of such investments for his specific situation.
A message from Advisor Perspectives and VettaFi: To learn more about this and other topics, check out some of our webcasts.
